Metropolis Healthcare schedules analyst meeting with Kotak Securities for March 25, 2026

Metropolis Healthcare Limited has announced an analyst and institutional investor meeting scheduled for March 25, 2026, in compliance with SEBI regulations. The company informed both BSE Limited and National Stock Exchange of India about this upcoming interaction through an official communication dated March 20, 2026.

Meeting Details

The scheduled meeting details are structured as follows:

Parameter:	Details
Date:	March 25, 2026
Time:	03:00 p.m. (IST) onwards
Host:	Kotak Securities
Type:	Group Meeting

Regulatory Compliance

The announcement was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has emphasized that discussions during the meeting will be based exclusively on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.

Important Considerations

Metropolis Healthcare has noted that changes to the meeting schedule may occur due to exigencies on the part of participants, host, or the company itself. The intimation has been made available on the company's official website at www.metropolisindia.com for stakeholder reference.

The communication was signed by Kamlesh C Kulkarni, Head – Legal & Secretarial, representing Metropolis Healthcare Limited in his official capacity.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.72%	-1.63%	-8.83%	-13.85%	+9.53%	-22.71%

Metropolis Healthcare Limited has successfully completed its postal ballot process for bonus shares issuance and has now announced the implementation timeline. Following overwhelming shareholder approval with 98.36% votes in favor, the company has fixed March 20, 2026 as the record date for determining shareholder entitlement for the 3:1 bonus equity shares issuance.

Record Date and Implementation Timeline

The Board of Directors, through a Circular Resolution passed on March 10, 2026, has established the complete implementation framework for the bonus shares issuance. The company communicated these details to stock exchanges through reference MHL/Sec&Legal/2025-26/97.

Parameter	Details
Record Date	Friday, March 20, 2026
Deemed Allotment Date	Monday, March 23, 2026
Bonus Ratio	3:1 (Three new shares for every existing share)
Face Value	INR 2/- per equity share
Total Paid-up Value	INR 10,36,63,884/-

Shareholder Approval and Voting Results

The postal ballot process concluded with decisive shareholder support, demonstrating strong confidence in the company's capital restructuring initiative. Sunny Gogiya from SGGS & Associates served as the scrutinizer for the comprehensive vote counting process.

Voting Results	Numbers	Percentage
Total Members (Cut-off Date)	46,467	-
Total Equity Shares	5,18,31,942	-
Votes in Favor	4,69,54,514	98.36%
Votes Against	7,84,503	1.64%
Invalid Votes	Nil	-

E-Voting Process and Documentation

The postal ballot was conducted exclusively through electronic voting, with National Securities Depository Limited serving as the Electronic Voting Service Provider. The e-voting period commenced on February 07, 2026 at 09:00 a.m. IST and concluded on March 08, 2026 at 05:00 p.m. IST.

Kamlesh C Kulkarni, Head – Legal & Secretarial, submitted the scrutinizer's report on March 09, 2026, confirming compliance with all regulatory requirements under Sections 108 and 110 of the Companies Act, 2013, and Regulation 44 of SEBI Listing Regulations.

Regulatory Compliance Framework

The bonus shares implementation follows SEBI Circular No. CIR/CFD/PoD/2024/122 dated September 16, 2024, which establishes the deemed allotment date framework. The entire process maintains transparency with voting results available on multiple platforms including the company's website at www.metropolisindia.com , NSDL's portal, and stock exchange websites.